Martin Rudwaleit

基本信息

Career Trajectory

Bio

Eines seiner Ziele ist die Etablierung einer klinischen Studienambulanz. Sie kann zukünftig Patient*innen einen sehr frühen Zugang zu neuen Therapien ermöglichen.

Research Interests

Papers共 116 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Improved Pain, Morning Stiffness, and Fatigue with Bimekizumab in Axial Spondyloarthritis: Results from the Phase III BE MOBILE Studies

Victoria Navarro-Compán,Martin Rudwaleit,Maureen Dubreuil,Marina Magrey,Helena Marzo-Ortega,Philip J Mease,Jessica A Walsh,Maxime Dougados,Christine de la Loge,Carmen Fleurinck,Ute Massow,Thomas Vaux,Vanessa Taieb,Atul Deodhar

The Journal of rheumatologyno. 1 (2025): 23-32

Cited0Views0WOSBibtex

Comparison of Established and Preliminarily Proposed ASAS MRI Working Group Cut-Offs for Inflammatory MRI Lesions in the Sacroiliac Joints in Radiographic and Non-Radiographic Axial Spondyloarthritis

Xenofon Baraliakos,Pedro M. Machado,Lars Bauer,Bengt Hoepken,Mindy Kim,Thomas Kumke,Rachel Tham,Martin Rudwaleit

RMD openno. 3 (2024)

Cited0Views0WOSBibtex

The Classification in Axial Spondyloarthritis Inception Cohort Study: Performance of the 2009 Assessments in Spondyloarthritis International Society Classification Criteria

Walter Maksymowych,Desiree van der Heijde,Liron Caplan,Robert Landewe,Lianne S. Gensler,Pedro M. Machado,Alexandre Sepriano,Floris van Gaalen,Miranda van Lunteren,Ben Vandermeer,Joachim Sieper,Atul Deodhar,Martin Rudwaleit

ARTHRITIS & RHEUMATOLOGY（2024）

Cited0Views0Bibtex

Achievement of Remission Defined by Absence of Objective Signs of Inflammation Versus ASDAS ID in Patients with Active Axial Spondyloarthritis Treated with Bimekizumab: 52-Week Results from Two Phase 3 Studies

Lianne S. Gensler,Helena Marzo-Ortega,Vanessa Taieb, Diana Voiniciuc,Alexander Marten,George Stojan,Mindy Kim,Martin Rudwaleit

ARTHRITIS & RHEUMATOLOGY (2024): 4772-4775

Cited0Views0Bibtex

Exploratory Analysis of the Potential Disconnect Between Objective Inflammatory Response and Clinical Response Following Certolizumab Pegol Treatment in Patients with Active Axial Spondyloarthritis

Martin Rudwaleit,Helena Marzo-Ortega,Victoria Navarro-Compan,Rachel Tham,Thomas Kumke,Lars Bauer,Natasha de Peyrecave,Mindy Kim,Filip van den Bosch

Annals of the Rheumatic Diseases（2023）

Cited0Views0WOSBibtex

The Role of HLA-B27 in the Pathogenesis and Diagnosis of Axial Spondyloarthritis

Jürgen Braun,Martin Rudwaleit,Joachim Sieper

Zeitschrift für Rheumatologieno. 2 (2023): 125-133

Cited0Views0Bibtex

POS0668 LOW UVEITIS RATES IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS TREATED WITH BIMEKIZUMAB: POOLED RESULTS FROM PHASE 2B/3 TRIALS

M. Rudwaleit,M. Brown,F. A. Van Gaalen,N. Haroon,L. S. Gensler,C. Fleurinck,A. Marten,U. Massow,N. De Peyrecave,T. Vaux,K. White,A. Deodhar,I. Van der Horst-Bruinsma

Scientific Abstracts (2023)

Cited4Views0Bibtex

Challenges in the Diagnosis of Axial Spondyloarthritis

Floris A. van Gaalen,Martin Rudwaleit

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY（2023）

Cited7Views0WOSBibtex

AB0986 QUALITY STANDARDS FOR PATIENTS WITH AXSPA – STATUS QUO OF DIAGNOSTIC AND THERAPEUTIC MANAGEMENT OF AXSPA PATIENTS IN GERMANY

J. F. Schmidt,U. Kiltz, C. Stammann, J. Schubert-Haack,J. Strunk,H. J. Lakomek,J. Braun,M. Rudwaleit

ANNALS OF THE RHEUMATIC DISEASES (2023): 1713-1713

Cited1Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Professor

Papers共 116 篇Author StatisticsCo-AuthorSimilar Experts